Dietary Nitrate on Plasma Nitrate Levels for Nasopharyngeal Carcinoma Patients
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02044562|
Recruitment Status : Unknown
Verified January 2014 by Songlin Wang, Capital Medical University.
Recruitment status was: Recruiting
First Posted : January 24, 2014
Last Update Posted : January 24, 2014
|Condition or disease||Intervention/treatment||Phase|
|Nasopharyngeal Carcinoma||Dietary Supplement: nitrate supplementation Dietary Supplement: Placebo||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||20 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Double (Participant, Investigator)|
|Official Title:||Study of Dietary Nitrate on Plasma Nitrate Levels for Nasopharyngeal Carcinoma Patients Receiving Concurrent Chemo-radiotherapy|
|Study Start Date :||September 2013|
|Estimated Primary Completion Date :||August 2014|
|Estimated Study Completion Date :||September 2014|
Experimental: nitrate supplementation
Patients will receive 7-day nitrate supplementation at the end of the radiotherapy.
Dietary Supplement: nitrate supplementation
A 70 ml beetroot juice containing 0.45g nitrate will be provided to the patients for 7 days at the end of the radiotherapy.
Placebo Comparator: Placebo
Patients will receive 7-day placebo supplementation at the end of the radiotherapy
Dietary Supplement: Placebo
A 70 ml placebo containing 0 g nitrate will be provided to the patients for 7 days at the end of the radiotherapy.
- plasma nitrate level [ Time Frame: one day after nitrate supplementation ]The plasma nitrate level will be determined one day after nitrate supplementation.
- quality of life [ Time Frame: one day after nitrate supplementation ]The quality of life will be assessed one day after nitrate supplementation.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02044562
|Capital Medical University School of Stomatology||Recruiting|
|Beijing, Beijing, China, 100050|
|Contact: Xingmin Qu 8610-57099421 firstname.lastname@example.org|
|Principal Investigator:||Songlin Wang, Ph.D||Professor and Vice President of Capital Medical University|